Role of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-induced conditioned place preference in adolescent mice

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Vidal Infer, Antonio ^a   Roger Sánchez, Concepción ^a   Daza Losada, Manuel ^a   Aguilar, María A ^a   Miñarro, José ^a   Rodríguez Arias, Marta ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; HALOPERIDOL; HOMOVANILLIC ACID; MONOAMINE; PENTIAPINE MALEATE; RACLOPRIDE; SEROTONIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONDITIONING; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; REINFORCEMENT; SEROTONIN BRAIN LEVEL;

ANIMALS; BENZAZEPINES; BLOTTING, WESTERN; CONDITIONING, OPERANT; DOPAMINE; DOPAMINE ANTAGONISTS; HALOPERIDOL; MALE; MICE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RACLOPRIDE; SEROTONIN; THIAZEPINES;

EID: 84865091763     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043107     Document Type: Article

References (78)

1. Solowij N, Hall W, Lee N, (1992) Recreational MDMA use in Sydney: a profile of ecstasy users and their experiences with the drug. Br J Addict 87: 1161-1172.
2. George J, Kinner SA, Bruno R, Degenhardt L, Dunn M, (2010) Contextualising psychological distress among regular ecstasy users: the importance of sociodemographic factors and patterns of drug use. Drug Alcohol Rev 29: 243-249.
3. Leung KS, Cottler LB, (2008) Ecstasy and other club drugs: a review of recent epidemiologic studies. Curr Opin Psychiatry 21: 234-241.
4. Di Chiara G, Imperato A, (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85: 5274-5278.
5. Robledo P, Mendizabal V, Ortuño J, de la Torre R, Kieffer BL, et al. (2004b) The rewarding properties of MDMA are preserved in mice lacking mu-opioid receptors. Eur J Neurosci 20: 853-858.
6. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI, (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55: 463-508.
7. Escobedo I, O'Shea E, Orio L, Sanchez V, Segura M, et al. (2005) A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice. Br J Pharmacol 144: 231-241.
8. Gough B, Ali SF, Slikker W, Holson RR, (1991) Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate. Pharmacol Biochem Behav 39: 619-623.
9. Hiramatsu M, Cho AK, (1990) Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: an in vivo microdialysis study. Neuropharmacology 29: 269-275.
10. Kankaanpää A, Meririnne E, Lillsunde P, Seppälä T, (1998) The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens. Pharmacol Biochem Behav 59: 1003-1009.
11. Schmidt CJ, Levin JA, Lovenberg W, (1987) In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem Pharmacol 36: 747-755.
12. Yamamoto BK, Spanos LJ, (1988) The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Eur J Pharmacol 148: 195-203.
13. O'Shea E, Escobedo I, Orio L, Sanchez V, Navarro M, et al. (2005) Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats. Neuropsychopharmacology 30: 1312-1323.
14. White SR, Duffy P, Kalivas PW, (1994) Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo. Neuroscience 62: 41-50.
15. Cadoni C, Solinas M, Pisanu A, Zernig G, Acquas E, et al. (2005) Effect of 3,4-methylendioxymethamphetamine (MDMA, "ecstasy") on dopamine transmission in the nucleus accumbens shell and core. Brain Res 1055: 143-148.
16. Daza-Losada M, Ribeiro Do Couto B, Manzanedo C, Aguilar MA, Rodríguez-Arias M, et al. (2007) Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice. Neuropsychopharmacology 32: 1750-1759.
17. Robledo P, Balerio G, Berrendero F, Maldonado R, (2004a) Study of the behavioural responses related to the potential addictive properties of MDMA in mice. Naunyn Schmiedebergs Arch Pharmacol 369: 338-349.
18. Ratzenboeck E, Saria A, Kriechbaum N, Zernig G, (2001) Reinforcing effects of MDMA ("ecstasy") in drug-naive and cocaine-trained rats. Pharmacology 62: 138-144.
19. Schenk S, Gittings D, Johnstone M, Daniela E, (2003) Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology 169: 21-27.
20. Trigo JM, Panayi F, Soria G, Maldonado R, Robledo P, (2006) A reliable model of intravenous MDMA self-administration in naïve mice. Psychopharmacology 184: 212-220.
21. Colussi-Mas J, Schenk S, (2008) Acute and sensitized response to 3,4-methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression. Eur J Neurosci 28: 1895-1910.
22. Ramos M, Goñi-Allo B, Aguirre N, (2004) Studies on the role of dopamine D1 receptors in the development and expression of MDMA-induced behavioral sensitization in rats. Psychopharmacology 177: 100-110.
23. Kalivas PW, Duffy P, White SR, (1998) MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology. 18: 469-479.
24. Callaway CW, Geyer MA, (1992) Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist. J Pharmacol Exp Ther 263: 318-326.
25. Daza-Losada M, Rodríguez-Arias M, Aguilar MA, Miñarro J, (2009) Acquisition and reinstatement of MDMA-induced conditioned place preference in mice pre-treated with MDMA or cocaine during adolescence. Addict Biol 14: 447-456.
26. Ribeiro Do Couto B, Daza-Losada M, Rodríguez-Arias M, Nadal R, Guerri C, et al. (2011) Adolescent pre-exposure to ethanol and 3,4-methylenedioxymethylamphetamine (MDMA) increases conditioned rewarding effects of MDMA and drug-induced reinstatement. Addict Biol in press.
27. Do Couto BR, Rodríguez-Arias M, Fuentes S, Gagliano H, Armario A, et al. (2011b) Adolescent pre-exposure to ethanol or MDMA prolongs the conditioned rewarding effects of MDMA. Physiol Behav 103: 585-593.
28. Daza-Losada M, Rodríguez-Arias M, Maldonado C, Aguilar MA, Miñarro J, (2008) Behavioural and neurotoxic long-lasting effects of MDMA plus cocaine in adolescent mice. Eur J Pharmacol 590: 204-211.
29. Aberg M, Wade D, Wall E, Izenwasser S, (2007) Effect of MDMA (ecstasy) on activity and cocaine conditioned place preference in adult and adolescent rats. Neurotoxicol Teratol 29: 37-46.
30. Schenk S, Hely L, Gittings D, Lake B, Daniela E, (2008) Effects of priming injections of MDMA and cocaine on reinstatement of MDMA- and cocaine-seeking in rats. Drug Alcohol Depend 96: 249-255.
31. Ball KT, Walsh KM, Rebec GV, (2007) Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues. Pharmacol Biochem Behav 87: 420-425.
32. Liechti ME, Vollenweider FX, (2000) Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans. Eur Neuropsychopharmacol 10: 289-295.
33. Kehne JH, Ketteler HJ, McCloskey TC, Sullivan CK, Dudley MW, et al. (1996) Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats. Neuropsychopharmacology 15: 116-124.
34. Ball KT, Budreau D, Rebec GV, (2003) Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors. Brain Res 994: 203-215.
35. Benturquia N, Courtin C, Noble F, Marie-Claire C, (2008) Involvement of D1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice. Brain Res 1211: 1-5.
36. Dragunow M, Logan B, Laverty R, (1991) 3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801. Eur J Pharmacol 206: 255-258.
37. Shirayama Y, Hashimoto K, Iyo M, Watanabe K, Higuchi T, et al. (2000) 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation. Eur J Pharmacol 402: 215-222.
38. Daniela E, Brennan K, Gittings D, Hely L, Schenk S, (2004) Effect of SCH 23390 on (+/-)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats. Pharmacol Biochem Behav 77: 745-750.
39. Brennan KA, Carati C, Lea RA, Fitzmaurice PS, Schenk S, (2009) Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats. Behav Pharmacol 20: 688-694.
40. Schenk S, Gittings D, Colussi-Mas J, (2011) Dopaminergic mechanisms of reinstatement of MDMA-seeking behaviour in rats. Br J Pharmacol 162: 1770-1780.
41. Bilsky EJ, Montegut MJ, Nichols ML, Reid LD, (1998) CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences. Pharmacol Biochem Behav 59: 215-220.
42. Plan Nacional sobre Drogas. ESTUDES: ENCUESTA ESTATAL SOBRE USO DE DROGAS EN ESTUDIANTES DE ENSEÑANZAS SECUNDARIAS (ESTUDES), 1994-2008. Available: http://www.pnsd.msc.es/Categoria2/observa/pdf/Estudes2008.pdf. Accessed 2012 July 23.
43. Schneider M, (2008) Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addict Biol 13: 253-263.
44. Colado MI, O'Shea E, Green AR, (2004) Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology 173: 249-263.
45. Simantov R, (2004) Multiple molecular and neuropharmacological effects of MDMA (Ecstasy). Life Sci 74: 803-814.
46. Heffner TG, Hartman JA, Seiden LS, (1980) A rapid method for the regional dissection of the rat brain. Pharmacol Biochem Behav 13: 453-456.
47. Di Chiara G, (1999) Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol 375: 13-30.
48. Tzschentke TM, (2007) Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12: 227-462.
49. Manzanedo C, Serrano A, Aguilar MA, Rodríguez-Arias M, Miñarro J, (2001a) Effects of CGS 10746B on hyperactivity and place preference induced by morphine. Behav Brain Res 126: 23-32.
50. Acquas E, Di Chiara G, (1994) D1 receptor blockade stereospecifically impairs the acquisition of drug-conditioned place-preference and place aversion. Behav Pharmacol 5: 555-569.
51. Acquas E, Carboni E, Leone P, Di Chiara G, (1989) SCH 23390 blocks drug-conditioned place-preference and place aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine receptor blockade? Psychopharmacology 99: 151-155.
52. Manzanedo C, Aguilar MA, Rodríguez-Arias M, Miñarro J, (2001b) Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice. Behav Brain Res 121: 189-197.
53. Sershen H, Hashim A, Lajtha A, (2010) Differences between nicotine and cocaine-induced conditioned place preferences. Brain Res Bull. 2010 Jan 15 81(1): 120-4.
54. Xu M, Guo Y, Vorhees CV, Zhang J, (2000) Behavioral responses to cocaine and amphetamine in D1 dopamine receptor mutant mice. Brain Res 852: 198-207.
55. Caine SB, Thomsen M, Gabriel KI, Berkowitz JS, Gold LH, et al. (2007) Lack of cocaine self-administration in dopamine D1 receptor knockout mice. J Neurosci 27: 13140-13150.
56. Chen L, Xu M, (2010) Dopamine D1 and D3 receptors are differentially involved in cue-elicited cocaine seeking. J Neurochem 114: 530-541.
57. Altar CA, Wesley AM, Liebman J, Geehardt S, Kim H, et al. (1986) CGS 10746B: An atypical antipsychotic candidate that selectively decreases dopamine release at behaviorally effective doses. Life Sci 39: 699-705.
58. Nair SG, Gudelsky GA, (2004) Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat. Brain Res 1013: 168-173.
59. Gudelsky GA, Nash JF, (1996) Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions. J Neurochem 66: 243-249.
60. Colussi-Mas J, Wise RJ, Howard A, Schenk S, (2010) Drug seeking in response to a priming injection of MDMA in rats: relationship to initial sensitivity to self-administered MDMA and dorsal striatal dopamine. Int J Neuropsychopharmacol 13: 1315-1327.
61. Beninger RJ, Wirsching BA, Jhamandas K, Boegman RJ, (1989) Animal studies of brain acetylcholine and memory. Arch Gerontol Geriatr 1: 71-89.
62. Fenu S, Bassareo V, Di Chiara G, (2001) A role for dopamine D1 receptors of the nucleus accumbens shell in conditioned taste aversion learning. J Neurosci 21: 6897-6904.
63. Bunney BS, Grace AA, (1978) Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life Sci. 23: 1715-1727.
64. Blaha CD, Lane RF, (1984) Direct in vivo electrochemical monitoring of dopamine release in response to neuroleptic drugs. Eur J Pharmacol 98: 113-117.
65. Imperato A, Di Chiara G, (1984) Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites. J Neurosci 4: 966-977.
66. Lidsky TI, Banerjee SP, (1993) Acute administration of haloperidol enhances dopaminergic transmission. J Pharmacol Exp Ther 265: 1193-1198.
67. Kapur S, Mamo D, (2003) Half a century of antipsychotics and still a central role for dopamine D2 receptors. Prog Neuropsychopharmacol Biol Psychiatry 27: 1081-1090.
68. Adams JU, Careri JM, Efferen TR, Rotrosen J, (2001) Differential effects of dopamine antagonists on locomotor activity, conditioned activity and conditioned place preference induced by cocaine in rats. Behav Pharmacol 12: 603-611.
69. Lawley SI, Kantak KM, (1990) Postconditioning effects of magnesium on cocaine conditioned place preference in mice. Pharmacol Biochem Behav 36: 531-538.
70. Liao RM, Chang YH, Wang SH, (1998) Influence of SCH23390 and spiperone on the expression of conditioned place preference induced by d-amphetamine or cocaine in the rat. Chin J Physiol 41: 85-92.
71. Weitemier AZ, Murphy NP, (2009) Accumbal dopamine and serotonin activity throughout acquisition and expression of place conditioning: correlative relationships with preference and aversion. Eur J Neurosci 29: 1015-1026.
72. Simón VM, Parra A, Miñarro J, Arenas MC, Vinader-Caerols C, et al. (2000) Predicting how equipotent doses of chlorpromazine, haloperidol, sulpiride, raclopride and clozapine reduce locomotor activity in mice. Eur Neuropsychopharmacol 10: 159-164.
73. Hyman SE, Malenka RC, Nestler EJ, (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29: 565-598.
74. Aguilar MA, Rodríguez-Arias M, Miñarro J, (2009) Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev 59: 253-77.
75. De Vries TJ, Schoffelmeer AN, Binnekade R, Raasø H, Vanderschuren LJ, (2002) Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization. Neuropsychopharmacology 26: 18-26.
76. Ettenberg A, MacConell LA, Geist TD, (1996) Effects of haloperidol in a response-reinstatement model of heroin relapse. Psychopharmacology 124: 205-210.
77. Shaham Y, Stewart J, (1996) Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats. Psychopharmacology 125: 385-391.
78. Ribeiro Do Couto B, Aguilar MA, Manzanedo C, Rodriguez-Arias M, Miñarro J, (2005) NMDA glutamate but not dopamine antagonists blocks drug-induced reinstatement of morphine place preference. Brain Res Bull 64: 493-503.